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A Peruvian woman was admitted to the Emergency Department, due to an acute 
flaccid paralysis (AFP) of the upper limbs that progressively involved also lower limbs 
and respiratory muscles. She previously suffered from non-Hodgkin’s lymphoma and 
had to undergo hematopoietic stem cell transplantation. A magnetic resonance imaging 
showed a T2 hyperintensity in the anterior and central region of the cervical segment 
with an elective involvement of gray matter. This finding, combined with other clinical, 
laboratory, and electrophysiological data, led to a diagnosis of AFP. Enterovirus D68 was 
isolated in the patient’s cerebrospinal fluid, plasma, and throat swab. To our knowledge, 
this is the first Italian case of AFP by Enterovirus D68 infection in an adult. The diagnostic 
assessment and management of AFP by Enterovirus D68 are discussed.
Keywords: acute flaccid paralysis, enterovirus D68, electrophysiology, nerve conduction study, eMG, poliomyelitis, 
bone marrow transplantation
INtRoDUCtIoN
Poliomyelitis is an acute, febrile illness caused by a wild-type poliovirus infection. Disease is char-
acterized by aseptic meningitis and weakness or paralysis of one or more extremities. Following 
the widespread use of polio vaccine, the incidence of poliomyelitis dramatically decrease in the 
western hemisphere and international eradication programs are making progress in the rest of the 
world. Nevertheless, sporadic cases of acute paralysis similar to poliomyelitis also occur with other 
enterovirus serotypes. In particular, Enterovirus D68 (D68V) has also been implicated in rare cases 
of acute paralysis in the United States (1–3). In the setting of a 2014 surge of respiratory illnesses 
due to D68V, there were reports of children with acute focal limb weakness and/or cranial nerve 
dysfunction, with a mild-to-moderate lymphocytic pleocytosis in the cerebrospinal fluid (CSF) 
and gray matter spinal cord lesions on magnetic resonance imaging (MRI), similar to poliomyelitis 
(4, 5). D68V was identified in nasopharyngeal specimens of a subset of these patients, but not from 
the CSF of any cases.
Acute flaccid paralysis (AFP) is the name used for a wide spectrum of neuromuscular diseases, 
ranging from acute inflammatory motor polyneuropathy to hypo/hyperkalemic paralysis and polio-
myelitis and polio-like infections (6–9). Despite the widespread use of polio vaccine, sporadic cases 
of acute paralysis similar to paralytic poliomyelitis also occur with other enterovirus serotypes. In 
particular, Enteroviruses are small, single-stranded RNA viruses of the Picornaviridae family that 
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share similar morphologies, structures, molecular properties, and 
replication strategies. They are commonly involved in both acute 
and chronic cardiac disease, hand, foot, and mouth disease, res-
piratory infections, herpangina, myositis, pleurodynia, eye infec-
tions, including acute haemorrhagic conjunctivitis, encephalitis, 
aseptic meningitis, and AFP (10). D68V was first described in 
California in 1962 in four children with severe respiratory tract 
infection and pneumonia; reports of D68V since then have been 
infrequent, with only 699 diagnoses being confirmed worldwide 
up to 2014, most of which induced pulmonary infections and 
sometimes AFP in children (11). Numerous cases, which caused 
severe respiratory illness in asthmatic children but were rarely 
associated with AFP, were described in 2014 in the USA. Since 
then, many D68V infections have been reported in Canada, 
Europe, and Asia, sometimes in association with AFP. Only one 
case of D68V associated with AFP has been described in Italy 
(11, 12). Some authors have described infections in Italy before 
(13) and after (14, 15) the 2014 outbreak, all of which were associ-
ated with severe respiratory symptoms. The comparative genomic 
analysis showed that most of the D68V strains circulating in the 
2014 outbreak in the USA differed significantly from prior strains 
(16), thereby indicating a viral evolution (17).
Immunocompromised hosts, such as patients with hemato-
logical malignancies receiving chemotherapy, including hemat-
opoietic stem cell transplant (HSCT) recipients, are susceptible to 
viral infection complications. To date, six cases of D68V infection 
have been reported in adult patients with hematological malig-
nancies who had undergone HSCT (18); all of these patients had 
respiratory diseases, and one was paraplegic as a result of a com-
pressive vertebral fracture. No cases of AFP have been reported.
We report the first case of AFP due to D68V in an adult trans-
planted patient affected by diffuse large B-cell non-Hodgkin’s 
lymphoma. Written informed consent was obtained from all the 
people whose identities could be revealed by data included in this 
case report.
Clinical Case
In April 2011, a 50-year-old Peruvian female who had been 
living in Italy for many years came to the hematology center 
of Policlinico Umberto I in Rome due to a bilateral inguinal 
lymphadenopathy. The diagnostic protocol led to a diagnosis of 
follicular non-Hodgkin’s B lymphoma (B-NHL) in stage IV of 
the disease. She underwent six cycles of GA101 (obinutuzumab)-
CHOP21 (cyclophosphamide, doxorubicin, vincristine, and 
prednisone), followed by five doses of GA101 (19), with complete 
remission. In November 2012, the patient presented a relapse 
of the disease, which had evolved into a diffuse large B-cell 
lymphoma. She received four cycles of the R-DHAP (rituximab, 
dexamethasone, cytarabine, cisplatin) treatment regimen (20), 
with a good response. In June 2013, she underwent an auto-HSCT 
after receiving the FEAM (fotemustine, etoposide, cytarabine, 
melphalan) conditioning regimen (21). Six months after the auto-
HSCT, owing to progression of the disease in the right humerus, 
she received local radiotherapy (total dose 30 Gy) and four cycles 
of the IEV protocol (epirubicin, ifosfamide, and etoposide) 
(22), which yielded a partial response. Since the patient had an 
HLA-matched family donor, in December 2014, she underwent 
an allo-HSCT after receiving a reduced intensity conditioning 
regimen with rituximab, cyclophosphamide, fludarabine, and 
thiotepa, according to the BCNHL protocol (23). Cyclosporine 
and methotrexate were used as the graft versus host disease 
(GVHD) prophylaxis.
After the transplant, the patient presented acute GVHD, 
with skin, liver, and gut involvement (grade IV), treated with 
high-dose corticosteroids and extracorporeal photopheresis. 
The GVHD evolved into a severe chronic GVHD. During this 
period, the patient displayed persistent CMV DNA-emia despite 
antiviral treatment with ganciclovir and foscarnet. The monitor-
ing of CD4+ lymphocytes in the peripheral blood showed a 
count persistently below 200/μl. In July 2016, she developed a 
Gram-negative sepsis, which resolved in 1 month. A low-grade 
fever persisted.
In early October 2016, the patient was admitted to the hema-
tological Emergency Department (ED) of Policlinico Umberto I 
in Rome after developing an acute proximal weakness of the left 
arm, with an impairment in lifting the same limb. She underwent 
a Doppler ultrasound of the left upper limb, which did not show 
any vascular involvement. Brain Computed Tomography and 
MRI were normal. As the strength deficit was mild [4/5 on the 
Medical Research Council (MRC) scale], she was discharged. The 
day after, the patient worsened, displaying a total impairment in 
arm elevation; a similar deficit had also extended to the proximal 
segment of the contralateral arm. A dropped head syndrome also 
occurred within a few hours. She was admitted to the central ED 
of our hospital.
The first neurological consultation revealed ptosis of the right 
eye lid, a severe motor deficit in the proximal muscles of the upper 
limbs (2/5 MRC scale, bilaterally), and a mild motor deficit in the 
distal muscles (4/5 MRC scale, bilaterally). Lower limb function 
was normal. There was no evidence of a sensory deficit. Deep 
tendon reflexes were absent in the upper limbs and normal in 
the lower limbs. Hoffmann sign was absent. The flexor plantar 
reflex was present bilaterally. Voluntary cough was feeble. Clinical 
features were suggestive of a man-in-the-barrel syndrome (24).
Considering the acute development of a motor deficit with 
no deep tendon reflexes in the upper limbs and the absence of 
sphincter involvement, a lumbar puncture was performed to 
exclude an acute inflammatory polyneuropathy, as were electro-
physiological assessments to exclude neuromuscular junction 
diseases such as myasthenia gravis or botulism. In the meantime, 
8 ml of CSF were collected for the physicochemical examination 
and microbiological assessments. A brain and spinal cord MRI 
was performed. The blood tests were normal except for a high 
C-reactive protein (12.99 mg/dl).
DIaGNostIC assessMeNts
The first lumbar puncture revealed mild pleocytosis with 
17 cells/μl (9 monocytes, 8 neutrophils). Other parameters were 
normal. CSF was tested for common neurotropic viruses by 
routine polymerase chain reaction (PCR) assays.
Spinal cord MRI revealed a swelling in the C2-T1 tract, with 
a T2 hyperintensity in the central region that enhanced after 
gadolinium injection. Imaging data were consistent with ischemic 
FIGURe 1 | Magnetic resonance imaging findings. Panel (a,B) show 
T2-weighted sagittal and axial images. Panel (C,D) show T1-contrast sagittal 
and axial images.
taBle 1 | Electrophysiological assessments.
R l Control values
sensory NCs
SCV (m/s)
Sural 48.0 45.0 >39.5
Ulnar 45.0 48.0 >45.0
Amplitude (μV)
Sural 16.3 15.8 >6.3
Ulnar 11.2 10.5 >7.5
Motor NCs
DML (ms)
Medial plantar 4.3 4.1 <4.8
Ulnar 2.5 2.2 <2.8
Median 2.8 2.9 <3.2
Phrenic 9.3 9.8 <9.5
MCV (m/s)
Medial plantar 46.0 48.0 >40.3
Ulnar 55.0 53.0 >50.4
Median 52.4 55.3 >51.4
Distal/proximal cMAP amplitude (mV)
Medial plantar (A/K) 11.2/11.0 12.3/11.9 >8.7
Ulnar (W/UE/AE/EP) 9.8/9.0/–/– 8.7/7.8/–/– >8.3
Median (W/E/EP) 13.1/12.7/–/– 12.6/11.8/–/– >9.0
Phrenic 0.2 0.3 >0.9
F-waves (ms)
Medial plantar 48.7 47.9 <54.3
Ulnar n.d. n.d. <27.6
Median n.d. n.d. <26.8
sep
Latency (ms)
Median: N20 16.2 17.0 <20.3
P25 18.9 19.5 <23.7
Tibial P40 40.8 39.9 <42.1
N45 45.0 43.3 <47.6
Amplitude (μV)
Median: N20-P25 2.2 2.4 >1.5
Tibial P40-N45 0.8 1.0 >0.6
NCS, nerve conduction study; SCV, sensory conduction velocity; DML, distal motor 
latency; MCV, motor conduction velocity; SEP, sensory-evoked potential; R, right; 
L, left; n.d., not detectable; A, ankle; K, knee; W, wrist; UE, under elbow; AE, above 
elbow; EP, Erb point; cMAP, compound motor action potential.
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damage or medullary localization of a lymphoma. A second 
opinion of the MRI scans revealed an elective T2-hyperintensity 
and gadolinium enhancement of the medullary gray matter, 
mainly involving the anterior horns (Figure 1). Steroid therapy 
with dexamethasone, ceftriaxone, and intravenous acyclovir was 
started.
An electrophysiological assessment was performed 4  days 
after admission. Owing to the weakness of the cough, the 
phrenic nerves were explored. Cathodal stimulation was supra-
maximally performed with a monopolar needle electrode 
positioned behind the sternocleidomastoid muscle, at the level 
of the cricoid cartilage. The anode was placed on the sternal 
manubrium (25). Compound motor action potential (cMAP) 
was recorded bilaterally using Ag/Cl electrodes placed over 
the eighth intercostal space, at the costochondral junction, 
referred to the opposite side. Electrophysiology yielded normal 
values for sensory nerve conduction as well as for the cMAP 
amplitude from the ulnar and median nerves bilaterally and 
the absence of F-waves. Motor conduction and F-waves in the 
lower limbs were normal. cMAP amplitudes from the phrenic 
nerves were below 30% of lower normal values. Data are shown 
in Table 1.
Repetitive nerve stimulation did not reveal any pre- or 
postsynaptic alteration in the neuromuscular junction safety 
factor, thus excluding myasthenia gravis and botulism. Electro-
myography did not detect any fibrillary elements; some satellite 
potential was present in the upper limb muscles, together with 
severe spatial recruitment deficit, with a proximal–distal gradi-
ent. Characteristically, doublets and triplets were observed in 
the upper limbs muscles. Needle electromyography from the 
diaphragm muscle was not performed.
Somatosensory-evoked potentials (SEP) were performed on 
the tibial and median nerves to confirm the lack of sensory signs 
that emerged at the clinical examination. Latency, amplitude, and 
morphology were normal bilaterally, thus confirming no involve-
ment of the posterior columns.
taBle 2 | Complete blood count.
Day 1 Day 3 Day 4 Day 4/2 Day 9
RBC 4,580 3,780 3,020 2,730 –
WBC 5,250 5,020 2,070 1,550 –
PLT 288 192 112 95 5
Days after admission to hospital.
RBC, red blood count; WBC, white blood count; PLT, platelet.
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In view of the results yielded by the electrophysiology, which 
suggested acute anterior horn damage, a second lumbar punc-
ture was performed. CSF and plasma samples for virus PCR 
[cytomegalovirus (CMV), Epstein–Barr (EBV), enterovirus A-D, 
herpes simplex (HSV) 1 and 2, human immunodeficiency virus 
(HIV), human herpesvirus 6-(HHV 6-), parechovirus, varicella 
zoster virus (VZV), and flavivirus] and IgM/IgG antibodies (anti-
polio 1, 2, and 3, West Nile, Coxsackie A and B 1–6, echovirus, 
adenovirus) and cytological data were collected, as were rectal 
and throat swabs.
The CSF analysis revealed a marked pleocytosis with 
130 cells/μl (125 monocytes and 5 polymorphonucleocytes), but 
normal glucose and protein levels. The cytological analysis did 
not detect any malignant lymphocyte in CSF. The viral analysis 
identified a D68V in the CSF, plasma, and throat swab. All other 
viral markers were negative, except for the mild presence of 
CMV-DNA in plasma.
Despite the reduction in cMAP amplitude in the phrenic nerves 
and the weakness of cough, the normal arterial blood gas values 
ruled out the need for an elective tracheotomy. However, 6 days 
after admission to hospital, the patient suffered from an acute 
respiratory failure and immediately underwent a tracheotomy. 
A chest X-ray showed the elevation of the hemi-diaphragms, thus 
confirming phrenic nerve involvement.
Intravenous immunoglobulins (IVIg) were dispensed as 
replacement therapy and passive immunization, as previously 
suggested (26–28), though without any clinical effect. The 
patient then developed a severe pancytopenia with a non-specific 
hypocellular marrow, as demonstrated by a biopsy. The complete 
blood count data are shown in Table 2. The patient underwent 
numerous blood component transfusions and received a bone 
marrow stimulant (filgrastim). Unfortunately, she passed away 
17 days after being admitted to hospital.
DIsCUssIoN
This is the first report of AFP induced by D68V in an adult stem 
cell transplanted patient in Italy. Only one child with AFP associ-
ated with D68V has previously been described in this country 
(12), though the authors of that report were unable to isolate 
the virus in the CSF. Most of the infected patients with D68V 
described previously were asthmatic children (11).
A number of differential diagnoses were considered. The 
patient’s clinical history was consistent with non-Hodgkin’s B 
lymphoma; the medullary localization of the disease was consid-
ered at first, though the specific involvement of medullary gray 
matter was unlikely because invasion of the spinal extradural 
space is the most frequent feature. Moreover, the thoracic seg-
ment is usually predominantly affected (29), and the cytological 
analysis did not reveal any malignant lymphocytes in the CSF.
A diagnosis of acute motor axonal neuropathy (AMAN) was 
also considered. MRI may highlight root enhancement in AMAN 
(30), whereas T2-hyperintensity and gadolinium enhancement of 
the spinal cord gray matter have not been reported. Nevertheless, 
other authors have reported myelitis associated with AMAN 
(31, 32), though clinical sensory impairment, sphincter dys-
functions, and Babinski sign, as well as a SEP impairment, are 
expected to accompany neuropathic signs. The marked pleocyto-
sis, especially in the second lumbar puncture, was suggestive of 
an infectious disease.
All the clinical and diagnostic findings pointed to a prevalent 
anterior horn involvement, even though the MRI revealed some 
T2-hyperintensity and gadolinium enhancement even in the 
posterior horns. The posterior, lateral, and ventral columns were 
clinically preserved, thus suggesting a marked tropism of the 
virus for gray matter.
The electrophysiological assessment confirmed this finding. 
SEP normality attested to the integrity of the peripheral and 
central somatosensory tracts. Conduction studies, performed 
some days after the clinical onset of the symptoms, yielded 
normal cMAP amplitude values in the upper limb nerves and 
the absence of F-waves, as is observed at the onset of Wallerian 
degeneration. These data were confirmed by needle EMG, which 
detected a reduced spatial recruitment. Fibrillation and positive 
sharp waves were not found, probably owing to the early timing 
of the examination. Doublets and triplets, often associated with 
both degenerative and inflammatory motor neuron diseases (25), 
were found.
The clinical assessment and laboratory, electrophysiological 
and MRI findings were in keeping with the diagnosis of poliomy-
elitis, initially made on the basis of the inflammatory involvement 
of gray matter in the spinal cord. Neurotropic pathogens associ-
ated with AFP, such as enterovirus A-D, EBV, HSV1 and 2, HIV, 
HHV 6, parechovirus, varicella zoster, flavivirus, poliovirus, West 
Nile, coxsackie A and B 1–6, echovirus and adenovirus, were 
investigated. PCR for CMV did detect this virus in plasma though 
not in the CSF. Enterovirus D, later characterized as D68V, was 
isolated in plasma, the throat swab and CSF. The presence of this 
neurotropic virus in biological fluids, together with the character-
istic polio-like clinical and diagnostic findings, suggest that D68V 
was the cause of the patient’s disease.
The phrenic nerve assessment proved to be a reliable means 
of predicting respiratory failure, as previously demonstrated in 
ALS patients (33–35), particularly when spirometry is not pos-
sible owing to limitations due to the illness (36). The chest X-ray 
and subsequent restrictive failure confirmed the diaphragmatic 
weakness. The arterial blood gas examination did not reveal 
any increase in pCO2 or reduction in pO2. We may speculate 
that other accessory respiratory muscles, such as intercostals, 
sternocleidomastoid, and trapezius muscle, which are innervated 
by nerves not originating in the C2-T1 tract, temporarily com-
pensated for the diaphragmatic deficit. Phrenic nerve assessment, 
when supported by clinical and imaging data, may be used to help 
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to decide how urgently needed a respiratory support is in neu-
romuscular diseases. Technical expedients, such as using needle 
stimulation, are required to avoid submaximal stimulation, which 
could give rise to misdiagnoses.
Other authors have described infections caused by D68V in 
patients with hematological malignancies or in HSCT-recipients 
presenting respiratory symptoms (18). D68V apparently shares 
tropism with poliovirus. Recent evidence (37) suggests that 
human pluripotent hematopoietic stem cells express CD155, a 
poliovirus receptor, and that poliovirus infects and replicates in 
human hematopoietic progenitor cell lines. This might explain the 
pancytopenia found in our patient. Moreover, we may speculate 
that the latent virus was transmitted through HSCT and started 
replicating after optimization of the immunosuppressive therapy 
due to the GVHD. Unfortunately, a viral assessment was not 
performed on the bone marrow biopsy.
Our patient did not respond to IVIg treatment. IVIg is commonly 
used in passive immunization or replacement immunotherapies 
in enterovirus infections in neonates and immunocompro-
mised patients (26–28). The effectiveness of IVIg treatments 
for enterovirus infections depends on the presence and level of 
anti-enterovirus neutralizing antibodies that are specific for the 
infecting serotype (27, 38, 39). IVIg treatment was also used for 
type 3 vaccine-derived poliovirus infection in an immunodefi-
cient Iranian child (40), though to little avail. By contrast, IVIg has 
proved effective in West Nile virus infections (41–45).
A recent study (46) showed that the 2014-D68V strain had 
some unique antigenic sites other than the prototype site. The 
authors of that study detected high titers of neutralizing antibod-
ies against both the prototype and 2014 strains, but significantly 
lower titers against the most recent strain in all IVIg lots they 
tested. However, it should be borne in mind that that study was 
performed in the US, where the 2014 outbreak started, and that 
US donors are more likely to be immunized against the 2014 
strain and, consequently, to have a more effective IVIg than Italian 
donors. An evaluation of enterovirus neutralizing antibodies 
from IVIg lots collected in different countries is needed.
CoNClUsIoN
This is the first description of AFP induced by D68V in an adult 
patient in Italy. D68V infection represents an emerging acute 
illness whose clinical course may resemble that of the polio 
infection. Physicians working in the emergency setting need to 
be aware of this potentially life-threatening disease. A multidis-
ciplinary approach is required for the diagnosis, which may be 
challenging. In particular, in our patient, the electrophysiological 
assessment highlighted the need to search for a polio-like virus. 
Interestingly, a reduction in cMAP amplitude in the phrenic 
nerves, when associated with clinical evidence of weakness of 
cough, may provide the indication for respiratory support.
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